Babu Yarlagadda S 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Mar 9, 2022
Insider Transaction Report
Form 4
Babu Yarlagadda S
VP Drug Discovery
Transactions
- Sale
Common Stock
2022-03-07$17.16/sh−20,000$343,200→ 230,056 total
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.05 to $17.27. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.